Trailing-twelve-month (TTM) revenue is $96.81 Million with a year-over-year growth of +7.87%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2024Period ended 2024-09-30 | $23,258,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2024-11-12 |
| Q4 FY2024Period ended 2024-12-31 | $31,131,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-03-11 |
| Q1 FY2025Period ended 2025-03-31 | $22,367,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-05-13 |
| Q2 FY2025Period ended 2025-06-30 | $20,054,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-08-13 |
| TTM revenue | $96,810,000 |
Current P/S: $4,376,523 market capitalization ÷ $96,810,000 TTM revenue = 0.05x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:12:25.000Z. Latest revenue period ended 2025-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2025 (2025-06-30): $20.05M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 8 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:37:12.686Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD |
|---|---|
| Asia | $12M |
| FRANCE | $26M |
| ISRAEL | $1M |
| Rest Of World Member | $4M |
| UNITED STATES | $29M |
$96.81M
$96.81 Million
+7.87%
vs. $89.75M a year ago (TTM)
+141.87%
3 Year compound annual growth rate
1 Year
+7.87%
3 Year
+141.87%
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2024 | $103.53M | +$25.55M | +32.76% |
| 2023 | $77.98M | +$28.95M | +59.04% |
| 2022 | $49.03M | +$41.72M | +570.58% |
| 2021 | $7.31M | +$2.57M | +54.23% |
TTM Growth
+7.87%
3-Year CAGR
+141.87%
5-Year CAGR
N/A
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:37:12.686Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
